Life Sciences

Can the RTS,S Vaccine Transform Malaria Prevention?
Care Can the RTS,S Vaccine Transform Malaria Prevention?

Overview of the Malaria Challenge Malaria remains one of the most pressing public health crises globally, with an estimated 263 million cases and 597,000 deaths recorded in the latest data for 2023, predominantly affecting populations in Africa. This devastating disease disproportionately impacts

Eli Lilly Acquires MeiraGTx Gene Therapy for Rare Eye Disorder
Business Eli Lilly Acquires MeiraGTx Gene Therapy for Rare Eye Disorder

Setting the Stage for a Transformative Market Shift In a landscape where rare diseases often languish without viable treatments, the gene therapy sector is emerging as a beacon of hope, particularly in ophthalmology. Consider the staggering reality that over 2 million people worldwide suffer from

MHRA and NICE Unite to Speed Up Medicine Access in UK
Care MHRA and NICE Unite to Speed Up Medicine Access in UK

Overview of UK Healthcare and Life Sciences Landscape The UK healthcare and life sciences sector stands at a pivotal moment, grappling with the dual challenge of meeting rising patient demands while fostering groundbreaking innovation. As a cornerstone of the national economy, this industry not

FDA Approves First Drug for Rare Mitochondrial Disease TK2d
Public Policy FDA Approves First Drug for Rare Mitochondrial Disease TK2d

Today, we’re diving into the groundbreaking world of mitochondrial disease treatments with Faisal Zain, a renowned healthcare expert specializing in medical technology. With his extensive experience in the development and manufacturing of cutting-edge medical devices, Faisal offers a unique p

How Will Thermo Fisher's $9B Clario Deal Boost Biopharma?
Business How Will Thermo Fisher's $9B Clario Deal Boost Biopharma?

I'm thrilled to sit down with Faisal Zain, a seasoned healthcare expert with a deep focus on medical technology. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal has a unique perspective on innovation in the biopharmaceutical industry.

GSK Expands COPD Pipeline with $85M Drug Acquisition
Care GSK Expands COPD Pipeline with $85M Drug Acquisition

In a landscape where chronic respiratory diseases continue to burden millions globally, a staggering statistic reveals that chronic obstructive pulmonary disease (COPD) ranks as one of the leading causes of death worldwide, affecting over 300 million people. This pressing health challenge has

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later